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An estimated 14.1 million patients survive sepsis hospitalization each year. Many 
survivors experience poor long-term outcomes, including new or exacerbated 
neuropsychological impairment, functional disability, and heightened vulnerability to 
further health deterioration, including recurrent infection, cardiovascular events, and 
acute renal failure. However, current guidelines and interventional trials have focused 
on shorter-term survival, so there is little data on how to best promote longer-term 
recovery. To address this unmet need, a Colloquium on “Understanding and Enhancing 
Sepsis Survivorship” was held in February 2018, sponsored by the International Sepsis 
Forum. The goals of the Colloquium were to identify (1) gaps and limitations of current 
research, (2) shorter-term research priorities, and (3) longer-term research priorities for 
understanding and enhancing sepsis survivorship, informed by review of the literature 
and expert opinion. A total of 26 experts from 8 countries participated. The top three 
short-term priorities were to better leverage existing databases for research, to develop 
and disseminate educational resources on post-sepsis morbidity, and to build deep 
connections with sepsis survivors to define and achieve research priorities. The top 
longer-term priorities were to link mechanisms to long-term outcomes through large 
cohort studies with deep phenotyping, build a harmonized global sepsis registry from 
which patients could be enrolled into cohort studies or interventional trials, and to 
complete detailed longitudinal follow-up to characterize the heterogeneity of recovery 
experiences across sepsis survivors. This Perspective reports on the Colloquium 
discussions, the rationale for the research priorities, and current initiatives addressing 
these priorities.  
 
Word Count: 242 
 






Sepsis—life-threatening organ dysfunction caused by a dysregulated host response to 
infection—is a leading cause of global morbidity and mortality. An estimated 14.1 million 
adults and 2.5 million children survive sepsis each year1,2, and many survivors 
experience poor long-term outcomes3. Patients develop an average 1-2 new functional 
limitations following sepsis4, and 10-40% experience new cognitive impairment4-7. 
Anxiety8, depression9, and post-traumatic stress disorder10 symptoms exceed 
population-level norms. Furthermore, sepsis survivors are vulnerable to further health 
problems3. Up to 40% are re-hospitalized within 90 days11, and rates of recurrent 
infection, sepsis, cardiovascular events, acute renal failure, and aspiration are 
increased relative to age- and co-morbidity matched controls3,12-14. As a result, sepsis 
survivors are often unable to live independently after sepsis15, cannot return to work16, 
and have increased risk of dying for up to two years17. Thus, sepsis should be viewed 
as a life-changing and disability-inducing event. 
 
A 2017 WHO resolution on sepsis called on member states to address the needs of 
survivors, recognizing the burden of longer-term sepsis-related morbidity18.  However, 
guidelines have traditionally focused on early recognition and management, not 
mitigation of longer-term sequelae19. Likewise, clinical trials typically use shorter-term 
mortality endpoints and only rarely collect data on functional outcomes or quality of 
life20,21. Perhaps not surprisingly given the lack of attention to sepsis survivorship, many 
patients report dissatisfaction with follow-up care after hospitalization22.  
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To address this unmet need, a Colloquium on “Understanding and Enhancing Sepsis 
Survivorship” was held in February 2018, sponsored by the International Sepsis Forum. 
The Colloquium brought together a diverse group of healthcare professionals, 
researchers, and patient representatives to distill essential findings on sepsis 
survivorship and articulate how to improve longer-term recovery. This Perspective 
reports on gaps and limitations of current knowledge on sepsis survivorship; research 
priorities and their rationale; and current initiatives to address these priorities.  
 
METHODS 
The Colloquium chairs (HCP, KMR, DCA) identified participants based on their 
expertise and through snowball sampling by recommendation.  Participants outside 
critical care and infectious disease were intentionally invited to provide experience and 
examples of successes in analogous areas.  Collectively, the group had expertise in 
sepsis, critical care, infectious diseases, geriatrics; physical medicine & rehabilitation, 
psychology, and physiotherapy.  
 
During the Colloquium, we used “nominal group technique” to rapidly gain consensus 
on research priorities. This process involves problem identification, solution generation, 
and decision making by group vote23.  Prior to Colloquium, participant were asked to 
consider gaps and limitations of current research (based on literature review and their 
expert opinion), then generate potential next steps to move the field forward. During the 
Colloquium, ideas were shared through presentations and group discussion (see Online 
Supplement, Appendix 1 for Colloquium agenda). At the end of the Colloquium, 
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participants listed potential next steps over a two-year and ten-year horizon—to “do 
more with what we have” in the shorter-term and “develop and deliver more” in the 
longer-term. Ideas were prioritized by group vote. Each participant could cast 12 votes, 
6 for shorter-term and 6 for longer-term priorities. Votes could be allocated in any way—
all 6 for a single idea or split amongst several ideas. Following the Colloquium, the 
organizing chairs drafted the manuscript, which was circulated to participants for critical 




Summary of Evidence 
Our discussion was informed by recent comprehensive reviews on adult sepsis 
survivorship3 and pediatric critical illness survivorship24. In addition, participants 
identified 30 recent systematic reviews pertinent to sepsis survivorship (Table 1). The 
main findings, as well as the gaps and limitations identified by these systematic reviews, 
are summarized in Supplemental Table 1.  
 
Limitations of Existing Research 
Participants identified the following limitations of as most important: (1) variable 
inclusion/exclusion criteria, outcomes measures, and timing of outcome assessments, 
making it difficult to pool studies to yield larger and more generalizable study 
populations, and (2) small or non-representative patient populations (Supplemental 
Tables 1, 2, Supplemental Figure 1).  
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Gaps in Research 
Participants identified the following gaps as most important: (1) limited data on longer-
term outcomes of specific patient populations, such as pediatric sepsis survivors and 
the majority of sepsis survivors who reside in low or middle-income countries; (2) limited 
data on outcomes beyond one year; (3) few studies of in-hospital or post-hospital 
interventions to enhance longer-term survival and quality of life; (4) limited data on how 
to identify patients most likely to benefit from interventions (Supplemental Tables 1, 3, 
Supplemental Figure 1). In particular, more research is needed to define the benefit 
and optimal delivery of early mobilization; physical rehabilitation; early cognitive 
rehabilitation; peer-support; supportive interventions for caregivers; and interventions to 
assist survivors in adapting to new limitations.  
 
Successes in Related Fields 
Relevant expert participants presented models of success in the fields of cancer, 
dementia, stroke, and traumatic brain injury that each have research programs 
promoting recovery and/or adaptation to new limitations (Table 2).  Dedicated follow-up 
clinics, which serve both to support patients and to generate and test research 
hypotheses, exist for each of these conditions in at least some countries. Additionally, 
these fields, particularly cancer, have large-scale public awareness campaigns, 
philanthropy-funded research programs, successful integration of patients into the 
prioritization of research questions, and large-scale longitudinal registries. These 
solutions should be adapted and applied to sepsis survivorship. 
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Is Sepsis Survivorship Unique? 
During the Colloquium, we considered the extent to which sepsis survivorship is a 
unique problem. Many challenges are shared with broader populations of patients 
surviving an acute illness25,26—as described by “post-hospital syndrome”27 (an acquired, 
transient period of generalized risk for a range of adverse health events); “post-intensive 
care syndrome”28 (new or worsened physical, cognitive, or emotional morbidity after 
critical illness); and “persistent inflammation, immunosuppression, and catabolism 
syndrome”29 (a collection persistent physiologic derangements following sepsis, trauma, 
or major surgery). Moreover, patients’ experiences after sepsis are often influenced by 
multi-morbidity, frailty, and progressively declining health prior to sepsis30,31. For this 
reason, the magnitude and type of post-sepsis problems measured in studies depends 
heavily on the comparison—whether sepsis survivors are compared to age- and 
gender-matched population controls, patients hospitalized for infection, or to other ICU 
patients. 
 
Despite the overlap with other populations, there are some benefits to focusing research 
and treatment on sepsis survivors rather than general ICU survivors. Serious sequelae 
of sepsis are not limited to patients treated in an ICU. Furthermore, organizing 
educational information around sepsis may be more accessible to patients, who rarely 
self-identify as ICU survivors. Indeed, a growing number of websites provide information 




The following themes emerged as central foci (Figure 2):  
 Promoting education, advocacy, and patient engagement. Awareness of sepsis 
sequelae is poor among general public and clinicians outside critical care. 
Advancing research and treatment of sepsis survivors requires broader 
awareness—to direct patients to existing resources, define and refine best 
practices for clinical management, and increase research funding. Finally, there 
is limited interaction between researchers and patient engagement groups, 
missing a critically important opportunity. 
 
 Building clinical infrastructure. Sepsis survivors are treated by a variety of 
healthcare providers across diverse clinical settings. Specialized follow-up, such 
as critical illness follow-up clinics or sepsis centers of excellence, is one possible 
approach to address the multi-faceted problems faced by sepsis survivors and 
mitigate secondary disabilities. By concentrating learning-by-doing and providing 
a setting to pilot and test novel rehabilitation strategies more efficiently, 
centralized follow-up programs may advance care.  For example, the Society of 
Critical Care Medicine’s International Thrive Collaboratives for ICU Peer 
Support37 and ICU Follow-up Clinics38 provide a setting to learn through shared 
experiences. However, because many sepsis survivors cannot travel to 
centralized clinics, care models must be expanded beyond traditional in-person 
clinics, potentially incorporating remote monitoring, telehealth, and in-home visits. 
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Alternatively, lessons learned from specialized follow-up clinics must be scaled 
for broader delivery. 
 
 Improving research methodology. Better research tools are needed to identify the 
mechanisms underlying post-sepsis morbidity and identify successful 
interventions. Particular areas of need include robust and proximal surrogate 
outcome measures that distinguish underlying mechanism of injury; measures 
that precisely characterize patient outcomes while minimizing response burden; 
theory-guided interventions (i.e., tailoring interventions to the mechanism/type of 
impairment), longer duration of longitudinal follow-up, and translational studies 
leveraging multi-modal assessment (from gene expression through patient 
reported outcomes).  
 
Prioritization of Short- and Long-Term Research Goals 
The top short-term priorities were: (1) merging ICU databases across countries and 
developing consensus harmonized data elements for such databases (15.2% of votes); 
(1) developing and disseminating educational materials for patients, families, and 
clinicians (15.2%); and (3) making deep connections with survivor groups to define and 
achieve research priorities (14.5%) (Figure 2). Full voting on short-term priorities is 
presented in Supplemental Table 5. 
 
Top long-term priorities were (1) building an integrated global cohort study linking 
mechanism to long-term outcomes (17.4% of votes); (2) building a global sepsis cohort 
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to feed into observational and interventional trials (15.9%), and (3) incorporating 
detailed long-term longitudinal follow up to characterize trajectories of 
recovery/survivorship across patients (14.5%) (Figure 2). Full voting on long-term 
priorities is presented in Supplemental Tables 6. 
 
Shorter-Term Priority 1: Harmonizing and linking existing ICU databases 
A number of high-quality ICU databases39-41, while not primarily developed for research, 
have proved valuable to answering research questions. Moreover, ICU databases have 
recently been developed in several lower and middle-income counties42-44. However, 
these databases are rarely linked to each other or to other data sources. As such, 
research questions are often limited to those that can be answered within the single 
database, constraining generalizability to select regions or hospital systems, and to the 
shorter-term outcomes collected.  
 
Investing in data linkages would realize the full potential of existing data, facilitate 
longer-term follow-up, and enable cross-system comparisons. For example, Brazil’s 
Organizational CHaractEriSTics in cRitical cAre study (ORCHESTRA) database was 
recently linked to the UK’s Intensive Care National Audits & Research Centre (ICNARC) 
Case Mix Programme database to compare prevalence and outcomes of ICU-treated 
sepsis between Brazil and England45. 
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Importantly, it is not necessary to share patient-level data. Rather, analyses can be 
completed in secure data enclaves46 or by pooling aggregate results, as was done for 
the Sepsis-3 validation47 and evaluation of US sepsis incidence48. 
 
Beyond linking existing databases, ICU dataset specifications should be harmonized, 
such that basic demographic, illness severity, and treatment data are collected in a 
consistent manner on consistent scales to facilitate comparison.    
 
Shorter-Term Priority 2: Developing and disseminating educational materials. 
Public awareness of sepsis has increased in recent years, but recognition still lags 
behind other acute medical conditions49, and awareness of long-term sequelae (e.g. 
physical and neuropsychological impairment, increased risk for recurrent infection) 
remains particularly low. The challenges of sepsis survivorship are not covered in 
current sepsis guidelines19 and are rarely discussed during hospitalization22,50.  
 
Several educational resources on sepsis survivorship have been developed 32,33,36,51,52. 
However, these materials must be disseminated more broadly. Panelists recommend: 
(1) educating patients and families about life after sepsis in the peri-discharge period; 
(2) developing and disseminating educational materials to clinicians working in post-
acute care facilities and the outpatient setting, such as this recent perspective on sepsis 
survivorship geared towards physical therapists53; and (3) incorporating education on 
sepsis sequelae into medical school curriculum, professional society conferences, and 
continuing medical education opportunities.  
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Shorter-Term Priority 3: Building deep connections with survivor groups to define 
and achieve research priorities.  
Patient advocacy groups play an important role in defining research priorities and 
funding research for many diseases.  For example, the Cystic Fibrosis Foundation funds 
drug development and randomized clinical trials. Their website reports that “nearly 
every CF drug was made possible by the Foundation and because of funds raised from 
Great Strides [walks]”54. 
 
Sepsis advocacy groups—such as Global Sepsis Alliance55, UK Sepsis Trust56, Latin 
American Sepsis Institute57, Sepsis Alliance58, and Rory Staunton Foundation59—have 
spurred large-scale awareness and quality improvement initiatives, such as World 
Sepsis Day60,61, nationwide quality improvement programs in Brazil62, and “Rory’s 
Regulations” in New York63,64. These efforts have saved lives. Moreover, in 2017, the 
World Health Organization passed a resolution recognizing sepsis as a global health 
priority18.   
 
Despite these successes, patients have historically been absent from defining sepsis 
research priorities. Going forward, researchers must better engage with sepsis survivors 
to advance sepsis research.  Recent examples of increased public involvement include: 
(1) collaboration of patients, caregivers, and clinicians to create the James Lind 
Alliance’s top 10 research questions for intensive care65; (2) inclusions of multiple public 
members on the current Surviving Sepsis Campaign Guidelines panel; (3) inclusion of 
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patient and caregiver representatives on the Delphi panel for developing core outcomes 
measures for acute respiratory distress syndrome survivors66,67; and (4) co-design of 
critical illness follow-up clinics by patients and clinicians68,69.  
 
Longer-Term Priorities:  
(1) A global cohort study linking mechanism to long-term outcomes;  
(2) A global sepsis registry, from which patients could be enrolled into 
observational and interventional studies;  
(3) Detailed long-term longitudinal follow up to characterize the heterogeneity of 
recovery across sepsis survivors. 
 
We believe the long-term priorities are best tackled jointly through a systematic 
research program on sepsis survivorship (Figure 3). The European Prevention of 
Alzheimer’s Dementia (EPAD) Consortium—a multi-national industry-academia initiative 
to “create a novel environment for testing numerous interventions targeted at the 
prevention of Alzheimer’s dementia”—could serve as a model70. EPAD aims to advance 
anti-dementia research and treatment by: (1) improving patients’ access to existing 
cohorts and registers; (2) developing a master registry of patients at increased risk of 
Alzheimer’s; (3) establishing a longitudinal cohort study of 6,000 patients; and (4) 
deploying a proof-of-concept adaptive trial, enrolling patients from the master registry of 
at-risk patients71. In essence, EPAD connects existing registries and serves as a unified 
entry point into early-phase clinical trials.  
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Similar infrastructure could dramatically accelerate sepsis research. Akin to EPAD, a 
sepsis consortium could start as a harmonized international registry, bringing together 
existing sepsis registries, such as the Mid-German Sepsis Cohort72. From the 
harmonized registry, patients could be screened and invited to join longitudinal cohort 
studies. Participation in the consortium could provide a venue for education and peer-
support, potentially providing immediate benefits to participants and encouraging 
retention. Over the longer-term, it would improve understanding of post-sepsis 
sequelae. Ultimately, adaptive platform trials could be incorporated to test putative 
interventions after sepsis. 
 
The major limitation to a free-standing sepsis consortium, however, is that data on pre-
sepsis health status could be collected only retrospectively. To overcome this limitation, 
the consortium could be embedded within large ongoing cohort studies (e.g. UK 
Biobank73, Norway’s HUNT Study74, US National Institutes of Health’s All of Us 
Research Program75, US Department of Veterans Affairs’ Million Veterans Program76), 
which already collect genetic and health data on millions of individuals.  
 
Cohort studies (e.g. US Health and Retirement Study77, Cardiovascular Health Study78), 
have already been leveraged to measure the impact of pre-sepsis health 
status/trajectory on sepsis outcomes30,79. However, in these studies, sepsis cases were 
identified by diagnosis codes in linked claims data, and there is limited data on patient 
outcomes in the months after sepsis hospitalization.  
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Prospectively embedding a sepsis consortium within ongoing cohort studies would 
provide several distinct benefits over existing research, including: (1) accurate 
identification of sepsis cases by prospectively collecting data on all potential sepsis 
hospitalizations, (2) better characterization of sepsis, and (3) increased intensively of 
data collection to characterize recovery after sepsis (e.g. serial collection of 
biospecimens and patient-reported outcomes). 
 
A global, harmonized sepsis consortium would be a natural arena to advance 
standardized core baseline variables and core outcome sets for sepsis80; refine their 
measurement across the continuum of sepsis; and develop platforms to collect such 
information across participating sites, drawing directly from electronic health records 
and existing databases when possible. The consortium could also promote non-
mortality outcomes, following the US Federal Drug Administration’s “Critical Path” 
process for proxy outcome development81, and select from existing (or develop new) 
IRT-based instruments to measure core outcomes in a way that maximizes information 
and minimizes participant burden.  
 
Sepsis survivorship research has often focused on a particular outcome (e.g. cognitive 
function, physical function, healthcare utilization) or a particular aspect of the underlying 
mechanistic pathways driving morbidity and mortality (e.g. genomics, transcriptomics, or 
proteomics in isolation). However, a sepsis consortium could support broad translational 
studies—simultaneously examining genomic and transcriptomic host response along 
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with multi-faceted patient outcomes—to understand the mechanisms driving the long-
term morbidity and mortality (Figure 2).  
 
Finally, while prior cohort studies have defined the average experience of patients in the 
year after sepsis, there is wide heterogeneity of experiences across individual patients. 
It is hypothesized that there are characteristic trajectories of recovery, adaptation, and 
ongoing/progressive disability after sepsis82. A sepsis consortium could support large, 
population-based cohorts with detailed longitudinal follow-up necessary to: (1) 
objectively identify and define the characteristic pathways of recovery versus disability 
after sepsis; (2) predict a patient’s likely post-sepsis trajectory; (3) identify modifiable 
factors influencing a patient’s recovery experience that could be targeted in future 
interventional studies (Figure 3).  
 
Additional areas of focus 
Beyond the top research priorities, there was considerable interest in: (1) developing an 
item-response theory (IRT) computerized adaptive testing (CAT) question bank for long-
term sepsis outcomes, and (2) developing better animal models of sepsis.  
 
Current instruments to assess post-sepsis outcomes (e.g. neuropsychological status, 
quality of life) may not detect subtle declines—but detailed assessments impose 
expense and respondent burden.  CAT characterizes a person’s ability more precisely 
and efficiently than standard surveys, is used widely in other settings (e.g. intelligence 
testing), and was recently used to study functional recovery after pediatric critical 
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illness83. CAT would be useful for characterizing heterogeneous outcomes of sepsis 
survivors, but questions must first be selected and calibrated for use.  
 
For pre-clinical studies, animal sepsis models reproduce many of the acute immune 
defects seen in septic patients, but are currently insufficient for studying longer term 
recovery. In most instances, animals are young, have no co-morbid disease, and are 
not treated with typical sepsis therapies (e.g. antibiotics, fluids, supplemental oxygen). 
Furthermore, as the goal is often to study short-term survival, animal models have been 
designed such that only a minority of animals survive the insult. These limitations have 
been addressed in a recent expert consensus initiative for improving animal modeling in 
sepsis, which aims to improve the translation of preclinical findings84. 
 
CONCLUSION 
Sepsis is a common cause of hospitalization that frequently results in new morbidity. 
Shorter-term priorities to improve outcomes for survivors include leveraging existing 
databases, improving awareness of post-sepsis morbidity, and connecting with sepsis 
survivors to define and achieve research priorities. Longer-term priorities are to 
understand the mechanisms driving long-term sequalae and characterize heterogeneity 
of recovery experiences, both of which will inform future interventions. These longer-
term priorities may be best accomplished through a global, harmonized sepsis research 
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Table 1: Recent Systematic Reviews Pertinent to Sepsis Survivorship 
Topic Number of Reviews, Total (Sepsis-Specific) 
Total Number of  
Included Studies 
Outcomes 
    Cognitive  385-87 (285,87) 168 
    Emotional  48-10,88 (0) 102 
    Functional  389-91 (0) 53 
    Mortality 21,92 (21,92) 69 
    Quality of Life 293,94 (193) 62 
    Other  295,96 (0) 44 
Interventions 
    Early Mobility  697-102 (1101) 88 
    Rehabilitation  3103-105 (0) 27 
    Other 4106-109 (0) 31 
Research Methods 
    Performance of 
outcome measures 1110 (0) 20 
Total  30 (6) 592 
Summaries of the 30 systematic reviews are presented in 
Supplemental Table 1. 
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Table 2: Models of success from other fields 
Analogous 
Condition Similarities Differences 
Successful programs, which may 
be appied to sepsis 
Cancer 
Like sepsis, cancer and its 
treatment commonly result 
in new morbidity, increased 
risk for certain medical 
complications, and post-
acute mortality.  
The duration of cancer 
treatment is longer, 
such that patients are 
more likely to self-
identify as cancer 
survivors. A defined 
specialty group provides 
both the acute and 
longer-term care. 
Large-scale registries, and an 
International Association of Cancer 
Registries59 
Registry-RCT linkages  
Public Awareness Campaigns  
Philanthropy-funded research  
Long-term follow-up clinics 
Peer Support Groups 
Dementia 
Like sepsis, dementia 
typically occurs in older 
patients with multi-morbidity 
and often requires family 
members to take on care-
giving roles. Like sepsis, 
dementia has suffered from 
a lack of targeted therapies 
entering the market despite 
improved understanding of 
its pathophysiology. 
Unlike sepsis, many 
dementias are slowly 
progressive diseases. A 
defined specialty group 
provides both the acute 
and longer-term care.  
Regional registries of dementia 
patients60. 
Industry-academia research 
collaboration with multi-national 
register, standardized follow-up, and 
intentional invitations to participate in 
early stage ‘adaptive’ clinical trials 
(e.g. European Prevention of 






Like sepsis, stroke and TBI 
may be followed by 
profound new functional 
and cognitive limitations. 
More focal injuries with 
discrete lesions and 
association functional 
and cognitive limitations. 
A defined specialty 
group provides both the 
acute and longer-term 
care. 
Structured acute rehabilitation and 
long-term follow-up programs.  







Figure 1: Shorter and longer-term research priorities by theme 
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Figure 2: Conceptual diagram of patients’ clinical course through sepsis and underlying factors that influence an 
individual patient’s trajectory 
 There are many potential clinical courses that a patient may experience after a hospitalization for sepsis, from rapid complete 
recovery to recurrent complications and death. This figure (adapted from a conceptual diagram first promoted in Prescott and Angus, 
JAMA, 20182) depicts common clinical trajectories (top panel) and presents factors important to shaping a patient’s clinical course 
and long-term outcome (bottom panel). This figure draws from the Wilson-Cleary model63, which links underlying biologic factors to 
 4 
physical function and quality of life, but extends the representation of the biologic factors to demonstrate their complex and 
unmeasurable interactions.  
 
Observable factors, such as presenting features and clinical manifestations of disease, are presented as light-grey ellipses, while the 
unmeasurable biological interactions are presented as dark-grey ellipses. Not all ellipses are labelled, representing our incomplete 
knowledge of the factors determining clinical course. This diagram is intended to convey that innumerable factors interact in complex 
ways to determine a patient’s long-term outcome, and that the measurable manifestations of disease cannot fully predict the 
evolution of a patient’s recovery because of the unmeasurable biological interactions at play.  
  
 5 
Figure 3: Conceptual diagram of global sepsis registry 
 
 While some services (education, emotional support) are ideally provided locally or regionally, they are not universally 
available. A global sepsis registry could provide universal opportunities for enrollment into cohorts and interventional trials, 
as well as safety net services for patients without local sepsis survivorship resources.  
